UNSPSC 51292603: Aptazapine

This classification denotes an antidepressant agent with the molecular formula C16H19N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 240J927J1R chemically known as (+/-)-1,3,4,14b-tetrahydro-2-methyl-2h,10h-pyrazino(1,2-a)pyrrolo(2,1-c)(1,4)benzodiazepine but generally known as aptazapine, which bears US NIH Compound Identifier 51355. European Medicines Agency schedules Aptazapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05547MIG.

UNSPSC 51292603 Aptazapine, a Commodity code, shows little relevant recent activity aligned with its nominal pharmaceutical scope. The single recent opportunity tagged under this code—Seminole County, Florida's IFB 60459723LAS—seeks procurement of naloxone and drug deactivation systems for community health delivery, which falls outside the aptazapine product classification. The mismatch between the code assignment and the actual procurement suggests either a data-entry error in the opportunity's coding or that this code does not reflect current state and local buying patterns for the pharmaceutical it nominally describes.

No representative solicitations for aptazapine itself appear in recent state and local procurement activity. Until the source surfaces opportunities that align the code with actual purchasing for this specific pharmaceutical, the code presents insufficient market signal to support a pursue decision based on current demand from state agencies, counties, municipalities, or other local bodies.